0001209191-11-056933.txt : 20111117
0001209191-11-056933.hdr.sgml : 20111117
20111117192855
ACCESSION NUMBER: 0001209191-11-056933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111115
FILED AS OF DATE: 20111117
DATE AS OF CHANGE: 20111117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE
CENTRAL INDEX KEY: 0001103390
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943200380
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-652-6500
MAIL ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE
DATE OF NAME CHANGE: 20000127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS STEPHEN
CENTRAL INDEX KEY: 0001131146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33734
FILM NUMBER: 111214490
MAIL ADDRESS:
STREET 1: NEUROGEN CORP
STREET 2: 35 NORTHEAST INDUSTRIAL RD
CITY: BRANFORD
STATE: CT
ZIP: 06405
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-11-15
0
0001103390
Ardea Biosciences, Inc./DE
RDEA
0001131146
DAVIS STEPHEN
4939 DIRECTORS PLACE
SAN DIEGO
CA
92121
0
1
0
0
EVP & COO
Common Stock
2011-11-15
4
S
0
432
18.8563
D
17331
D
The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010.
The range of sales prices received was $18.67 to $18.995. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Includes 576 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on November 14, 2011.
/s/ Christian Waage
Attorney-in-fact for Stephen Davis
2011-11-17